Zuern, K., Hielscher, T., Werly, A., Breitkreutz, I., Sauer, S., Raab, M. S., . . . Mai, E. K. (2024). Longitudinal assessment of established risk stratification models in patients with monoclonal gammopathy of undetermined significance. Blood Cancer Journal, 14(1), . https://doi.org/10.1038/s41408-024-01126-3
Chicago Style (17th ed.) CitationZuern, Kosima, Thomas Hielscher, Annika Werly, Iris Breitkreutz, Sandra Sauer, Marc S. Raab, Carsten Müller-Tidow, Hartmut Goldschmidt, and Elias K. Mai. "Longitudinal Assessment of Established Risk Stratification Models in Patients with Monoclonal Gammopathy of Undetermined Significance." Blood Cancer Journal 14, no. 1 (2024). https://doi.org/10.1038/s41408-024-01126-3.
MLA (9th ed.) CitationZuern, Kosima, et al. "Longitudinal Assessment of Established Risk Stratification Models in Patients with Monoclonal Gammopathy of Undetermined Significance." Blood Cancer Journal, vol. 14, no. 1, 2024, https://doi.org/10.1038/s41408-024-01126-3.